Genetic Engineering News
June 22, 2006 by admin
Filed under Media Reports, Media Reports 2006
| Novotech Presents Checklist for CRO Partnering and Trials Selection in Australia & Asia at DIA 2006; Frost & Sullivan Asia Pacific Healthcare Best Practice Award 2006 Recipient Novotech, the largest Australian owned contract research organization (CRO) presented to the Drug Industry Association (DIA} annual conference 2006 this week, a check list for the selection of a CRO in Australia and the Asian region. At Novotech’s DIA press conference, Novotech CEO Alek Safarian said all eyes were currently on the Australian and Asian region for drug trials and research and the checklist would help guide international CROs, biotechs and pharmas to make the right choice to suit their needs. |
For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1007  |
